Boiron SA (EPA:BOI)

Market Cap	468.78M
Revenue (ttm)	504.86M
Net Income (ttm)	19.37M
Shares Out	17.36M
EPS (ttm)	1.12
PE Ratio	24.20
Forward PE	17.29
Dividend	1.20 (4.44%)
Ex-Dividend Date	Jun 3, 2025

Volume	1,413
Average Volume	1,327
Open	26.55
Previous Close	27.00
Day's Range	26.10 - 26.95
52-Week Range	20.85 - 32.75
Beta	0.35
RSI	45.73
Earnings Date	Oct 29, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for ad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.